Go Deep
Windlas Biotech Limited
Windlas Biotech Limited Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 23,048 | 29.3 | 3.26 | 0.06 | 917.30 |
Windlas Biotech Limited Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 2,480,990,000.0 | 2,384,990,000.0 | 2,331,020,000.0 | 2,223,980,000.0 |
| Net Profit | 176,530,000.0 | 159,900,000.0 | 150,020,000.0 | 178,000,000.0 |
| EPS | 8.5 | 7.6 | 7.1 | 8.5 |
Windlas Biotech Limited Revenue & Profit: Last 5 Years
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Revenue | 8,976,960,000.0 | 7,551,260,000.0 | 6,288,850,000.0 | 5,105,810,000.0 | — |
| Net Profit | 664,560,000.0 | 609,940,000.0 | 581,870,000.0 | 426,260,000.0 | — |
| EPS | 31.6 | 29.2 | 28.0 | 19.7 | — |
Windlas Biotech Limited Balance Sheet
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Total Assets | 9,073,480,000.0 | 7,604,500,000.0 | 6,262,060,000.0 | 5,289,750,000.0 | — |
| Total Liabilities | 3,265,100,000.0 | 2,546,780,000.0 | 1,762,700,000.0 | 1,267,040,000.0 | — |
| Total Equity | 5,808,380,000.0 | 5,057,720,000.0 | 4,499,360,000.0 | 4,022,710,000.0 | — |
Owes vs Owns
Windlas Biotech Limited owed ₹0.36 for every ₹1 it owned in Mar 2026, up from ₹0.24 in Mar 2023.
| Period | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Owes vs Owns | 0.36× | 0.33× | 0.28× | 0.24× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Windlas Biotech Limited Assets & Liabilities Breakdown (₹ Cr)
What it owns — Mar 2026
Cash & short-term investments 30.7%Receivables 25.1%Inventory 6.8%Fixed assets (tangible) 29.4%Intangible assets 0.8%Long-term investments 0.7%Other assets 6.5%
How it's funded — Mar 2026
Short-term debt 3.3%Payables 26.3%Other liabilities 6.2%Shareholders' equity 64.0%
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 278.8 | 239.3 | 203.2 | 130.7 |
| Receivables | 227.4 | 166.9 | 136.3 | 116.9 |
| Inventory | 61.8 | 81.4 | 62.2 | 74.7 |
| Fixed assets (tangible) | 266.9 | 223.6 | 185.1 | 161.5 |
| Intangible assets | 6.9 | 6.8 | 4.5 | 1.5 |
| Long-term investments | 6.3 | 0.1 | 1.6 | 5.2 |
| Other assets | 59.3 | 42.5 | 33.3 | 38.5 |
| Liabilities & equity | ||||
| Short-term debt | 29.9 | 27.1 | 0.1 | 0.3 |
| Long-term debt | 2.1 | 0.0 | 0.0 | 0.1 |
| Payables | 238.5 | 177.8 | 131.5 | 87.7 |
| Other liabilities | 56.0 | 49.7 | 44.6 | 38.5 |
| Shareholders' equity | 580.8 | 505.8 | 449.9 | 402.3 |
| Net tangible assets | 573.9 | 499.0 | 445.5 | 400.8 |
Windlas Biotech Limited Cash Flow
| Line Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
| Operating Activities | 1,049,340,000.0 | 681,870,000.0 | 1,089,600,000.0 | 609,650,000.0 | — |
| Investing Activities | -917,910,000.0 | -740,640,000.0 | -920,680,000.0 | -141,100,000.0 | — |
| Financing Activities | -130,320,000.0 | 10,130,000.0 | -152,900,000.0 | -437,390,000.0 | — |